Sfoglia per Autore
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms.
2011-01-01 Elena, Chiara; Rumi, Elisa; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, F.
Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
2012-01-01 Milosevic, Jd; Puda, A; Malcovati, Luca; Berg, T; Hofbauer, M; Stukalov, A; Klampfl, T; Harutyunyan, As; Gisslinger, H; Gisslinger, B; Burjanivova, T; Rumi, Elisa; Pietra, D; Elena, Chiara; Vannucchi, Am; Doubek, M; Dvorakova, D; Robesova, B; Wieser, R; Koller, E; Suvajdzic, N; Vannucchi Tomin, D; Tosic, N; Colinge, J; Racil, Z; Steurer, M; Pavlovic, S; Cazzola, Mario; Kralovics, R.
JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms.
2012-01-01 Pietra, D; Casetti, I; Da Vià, Mc; Elena, Chiara; Milanesi, C; Rumi, Elisa
Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm.
2012-01-01 Rumi, Elisa; Casetti, I; Pietra, D; Elena, Chiara; Ambaglio, I; Pascutto, C; Passamonti, F; Cazzola, Mario
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
2012-01-01 Puda, A; Milosevic, Jd; Berg, T; Klampfl, T; Harutyunyan, As; Gisslinger, B; Rumi, Elisa; Pietra, D; Malcovati, Luca; Elena, Chiara; Doubek, M; Steurer, M; Tosic, N; Pavlovic, S; Guglielmelli, P; Pieri, L; Vannucchi, Am; Gisslinger, H; Cazzola, Mario; Kralovics, R.
Somatic mutations of calreticulin in myeloproliferative neoplasms
2013-01-01 Klampfl, T; Gisslinger, H; Harutyunyan, As; Nivarthi, H; Rumi, Elisa; Milosevic, Jd; Them, Nc; Berg, T; Gisslinger, B; Pietra, D; Chen, D; Vladimer, Gi; Bagienski, K; Milanesi, C; Casetti, Ic; Sant'Antonio, E; Ferretti, V; Elena, Chiara; Schischlik, F; Cleary, C; Six, M; Schalling, M; Schönegger, A; Bock, C; Malcovati, Luca; Pascutto, C; Superti Furga, G; Cazzola, Mario; Kralovics, R.
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2.
2013-01-01 Klampfl, T; Milosevic, Jd; Puda, A; Schönegger, A; Bagienski, K; Berg, T; Harutyunyan, As; Gisslinger, B; Rumi, Elisa; Malcovati, Luca; Pietra, D; Elena, Chiara; DELLA PORTA, MATTEO GIOVANNI; Pieri, L; Guglielmelli, P; Bock, C; Doubek, M; Dvorakova, D; Suvajdzic, N; Tomin, D; Tosic, N; Racil, Z; Steurer, M; Pavlovic, S; Vannucchi, Am; Cazzola, Mario; Gisslinger, H; Kralovics, R.
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.
2014-01-01 Malcovati, Luca; Papaemmanuil, E; Ambaglio, I; Elena, Chiara; Gallì, A; DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Pietra, D; Pascutto, C; Ubezio, M; Bono, E; Da Vià, Mc; Brisci, A; Bruno, F; Cremonesi, L; Ferrari, M; Boveri, E; Invernizzi, Rosangela; Campbell, Pj; Cazzola, Mario
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
2014-01-01 Rumi, Elisa; Pietra, D; Ferretti, V; Klampfl, T; Harutyunyan, As; Milosevic, Jd; Them, Nc; Berg, T; Elena, Chiara; Casetti, Ic; Milanesi, C; Sant'Antonio, E; Bellini, M; Fugazza, E; Renna, Mc; Boveri, E; Astori, C; Pascutto, C; Kralovics, R; Cazzola, Mario
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
2014-01-01 Randi, Ml; Bertozzi, I; Rumi, Elisa; Elena, Chiara; Finazzi, G; Vianelli, N; Polverelli, N; Ruggeri, M; Vannucchi, Am; Antonioli, E; Lussana, F; Tieghi, A; Iurlo, A; Elli, E; Ruella, M; Fabris, F; Cazzola, Mario; Barbui, T.
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
2014-01-01 Lussana, F; Carobbio, A; Randi, Ml; Elena, Chiara; Rumi, Elisa; Finazzi, G; Bertozzi, I; Pieri, L; Ruggeri, M; Palandri, F; Polverelli, N; Elli, E; Tieghi, A; Iurlo, A; Ruella, M; Cazzola, Mario; Rambaldi, A; Vannucchi, Am; Barbui, T.
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
2014-01-01 Verstovsek, S; Passamonti, Francesco; Rambaldi, A; Barosi, G; Rosen, Pj; Rumi, Elisa; Gattoni, E; Pieri, L; Guglielmelli, P; Elena, Chiara; He, S; Contel, N; Mookerjee, B; Sandor, V; Cazzola, Mario; Kantarjian, Hm; Barbui, T; Vannucchi, A. M.
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications
2015-01-01 Malcovati, Luca; Ambaglio, Ilaria; Elena, Chiara
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
2015-01-01 Mori, Silvia; Vagge, Elisabetta; Le Coutre, Philipp; Abruzzese, Elisabetta; Martino, Bruno; Pungolino, Ester; Elena, Chiara; Pierri, Ivana; Assouline, Sarit; D'Emilio, Anna; Gozzini, Antonella; Giraldo, Pilar; Stagno, Fabio; Iurlo, Alessandra; Luciani, Michela; De Riso, Giulia; Redaelli, Sara; Kim, Dong Wook; Pirola, Alessandra; Mezzatesta, Caterina; Petroccione, Anna; Lodolo D'Oria, Agnese; Crivori, Patrizia; Piazza, ROCCO GIOVANNI; Gambacorti Passerini, Carlo
Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis
2015-01-01 Orlandi, Ester M; Elena, Chiara; Zibellini, Silvia
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
2015-01-01 DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Boveri, E; Ponzoni, M; Malcovati, Luca; Papaemmanuil, E; Rigolin, Gm; Pascutto, C; Croci, G; Gianelli, U; Milani, R; Ambaglio, I; Elena, Chiara; Ubezio, M; Da Via', Mc; Bono, E; Pietra, D; Quaglia, F; Bastia, R; Ferretti, V; Cuneo, A; Morra, E; Campbell, Pj; Orazi, A; Invernizzi, Rosangela; Cazzola, Mario
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: A real clinical problem?
2015-01-01 Iurlo, Alessandra; Orsi, Emanuela; Cattaneo, Daniele; Resi, Veronica; Bucelli, Cristina; Orofino, Nicola; Sciumè, Mariarita; Elena, Chiara; Grancini, Valeria; Consonni, Dario; Orlandi, Ester Maria; Cortelezzi, Agostino
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms
2015-01-01 Pecci, Alessandro; Necchi, Vittorio; Barozzi, Serena; Vitali, Agostina; Boveri, Emanuela; Elena, Chiara; Bernasconi, Paolo; Noris, Patrizia; Solcia, Enrico
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
2015-01-01 Malcovati, Luca; Karimi, M; Papaemmanuil, E; Ambaglio, I; Jädersten, M; Jansson, M; Elena, Chiara; Gallì, A; Walldin, G; DELLA PORTA, MATTEO GIOVANNI; Raaschou Jensen, K; Travaglino, E; Kallenbach, K; Pietra, D; Ljungström, V; Conte, S; Boveri, E; Invernizzi, Rosangela; Rosenquist, R; Campbell, Pj; Cazzola, Mario; Hellström Lindberg, E.
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
2016-01-01 Elena, Chiara; Galli', Anna; Such, E; Meggendorfer, M; Germing, U; Rizzo, Ettore; Cervera, J; Molteni, Elisabetta; Fasan, A; Schuler, E; Ambaglio, Ilaria; Lopez Pavia, M; Zibellini, S; Kuendgen, A; Travaglino, E; Sancho Tello, R; Catricala', Silvia; Vicente, Ai; Haferlach, T; Haferlach, C; Sanz, Gf; Malcovati, Luca; Cazzola, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms. | 1-gen-2011 | Elena, Chiara; Rumi, Elisa; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, F. | |
| Clinical significance of genetic aberrations in secondary acute myeloid leukemia. | 1-gen-2012 | Milosevic, Jd; Puda, A; Malcovati, Luca; Berg, T; Hofbauer, M; Stukalov, A; Klampfl, T; Harutyunyan, As; Gisslinger, H; Gisslinger, B; Burjanivova, T; Rumi, Elisa; Pietra, D; Elena, Chiara; Vannucchi, Am; Doubek, M; Dvorakova, D; Robesova, B; Wieser, R; Koller, E; Suvajdzic, N; Vannucchi Tomin, D; Tosic, N; Colinge, J; Racil, Z; Steurer, M; Pavlovic, S; Cazzola, Mario; Kralovics, R. | |
| JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms. | 1-gen-2012 | Pietra, D; Casetti, I; Da Vià, Mc; Elena, Chiara; Milanesi, C; Rumi, Elisa | |
| Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm. | 1-gen-2012 | Rumi, Elisa; Casetti, I; Pietra, D; Elena, Chiara; Ambaglio, I; Pascutto, C; Passamonti, F; Cazzola, Mario | |
| Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. | 1-gen-2012 | Puda, A; Milosevic, Jd; Berg, T; Klampfl, T; Harutyunyan, As; Gisslinger, B; Rumi, Elisa; Pietra, D; Malcovati, Luca; Elena, Chiara; Doubek, M; Steurer, M; Tosic, N; Pavlovic, S; Guglielmelli, P; Pieri, L; Vannucchi, Am; Gisslinger, H; Cazzola, Mario; Kralovics, R. | |
| Somatic mutations of calreticulin in myeloproliferative neoplasms | 1-gen-2013 | Klampfl, T; Gisslinger, H; Harutyunyan, As; Nivarthi, H; Rumi, Elisa; Milosevic, Jd; Them, Nc; Berg, T; Gisslinger, B; Pietra, D; Chen, D; Vladimer, Gi; Bagienski, K; Milanesi, C; Casetti, Ic; Sant'Antonio, E; Ferretti, V; Elena, Chiara; Schischlik, F; Cleary, C; Six, M; Schalling, M; Schönegger, A; Bock, C; Malcovati, Luca; Pascutto, C; Superti Furga, G; Cazzola, Mario; Kralovics, R. | |
| Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. | 1-gen-2013 | Klampfl, T; Milosevic, Jd; Puda, A; Schönegger, A; Bagienski, K; Berg, T; Harutyunyan, As; Gisslinger, B; Rumi, Elisa; Malcovati, Luca; Pietra, D; Elena, Chiara; DELLA PORTA, MATTEO GIOVANNI; Pieri, L; Guglielmelli, P; Bock, C; Doubek, M; Dvorakova, D; Suvajdzic, N; Tomin, D; Tosic, N; Racil, Z; Steurer, M; Pavlovic, S; Vannucchi, Am; Cazzola, Mario; Gisslinger, H; Kralovics, R. | |
| Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. | 1-gen-2014 | Malcovati, Luca; Papaemmanuil, E; Ambaglio, I; Elena, Chiara; Gallì, A; DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Pietra, D; Pascutto, C; Ubezio, M; Bono, E; Da Vià, Mc; Brisci, A; Bruno, F; Cremonesi, L; Ferrari, M; Boveri, E; Invernizzi, Rosangela; Campbell, Pj; Cazzola, Mario | |
| JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. | 1-gen-2014 | Rumi, Elisa; Pietra, D; Ferretti, V; Klampfl, T; Harutyunyan, As; Milosevic, Jd; Them, Nc; Berg, T; Elena, Chiara; Casetti, Ic; Milanesi, C; Sant'Antonio, E; Bellini, M; Fugazza, E; Renna, Mc; Boveri, E; Astori, C; Pascutto, C; Kralovics, R; Cazzola, Mario | |
| Pregnancy complications predict thrombotic events in young women with essential thrombocythemia | 1-gen-2014 | Randi, Ml; Bertozzi, I; Rumi, Elisa; Elena, Chiara; Finazzi, G; Vianelli, N; Polverelli, N; Ruggeri, M; Vannucchi, Am; Antonioli, E; Lussana, F; Tieghi, A; Iurlo, A; Elli, E; Ruella, M; Fabris, F; Cazzola, Mario; Barbui, T. | |
| A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. | 1-gen-2014 | Lussana, F; Carobbio, A; Randi, Ml; Elena, Chiara; Rumi, Elisa; Finazzi, G; Bertozzi, I; Pieri, L; Ruggeri, M; Palandri, F; Polverelli, N; Elli, E; Tieghi, A; Iurlo, A; Ruella, M; Cazzola, Mario; Rambaldi, A; Vannucchi, Am; Barbui, T. | |
| A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea | 1-gen-2014 | Verstovsek, S; Passamonti, Francesco; Rambaldi, A; Barosi, G; Rosen, Pj; Rumi, Elisa; Gattoni, E; Pieri, L; Guglielmelli, P; Elena, Chiara; He, S; Contel, N; Mookerjee, B; Sandor, V; Cazzola, Mario; Kantarjian, Hm; Barbui, T; Vannucchi, A. M. | |
| The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications | 1-gen-2015 | Malcovati, Luca; Ambaglio, Ilaria; Elena, Chiara | |
| Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study | 1-gen-2015 | Mori, Silvia; Vagge, Elisabetta; Le Coutre, Philipp; Abruzzese, Elisabetta; Martino, Bruno; Pungolino, Ester; Elena, Chiara; Pierri, Ivana; Assouline, Sarit; D'Emilio, Anna; Gozzini, Antonella; Giraldo, Pilar; Stagno, Fabio; Iurlo, Alessandra; Luciani, Michela; De Riso, Giulia; Redaelli, Sara; Kim, Dong Wook; Pirola, Alessandra; Mezzatesta, Caterina; Petroccione, Anna; Lodolo D'Oria, Agnese; Crivori, Patrizia; Piazza, ROCCO GIOVANNI; Gambacorti Passerini, Carlo | |
| Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis | 1-gen-2015 | Orlandi, Ester M; Elena, Chiara; Zibellini, Silvia | |
| Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes | 1-gen-2015 | DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Boveri, E; Ponzoni, M; Malcovati, Luca; Papaemmanuil, E; Rigolin, Gm; Pascutto, C; Croci, G; Gianelli, U; Milani, R; Ambaglio, I; Elena, Chiara; Ubezio, M; Da Via', Mc; Bono, E; Pietra, D; Quaglia, F; Bastia, R; Ferretti, V; Cuneo, A; Morra, E; Campbell, Pj; Orazi, A; Invernizzi, Rosangela; Cazzola, Mario | |
| Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: A real clinical problem? | 1-gen-2015 | Iurlo, Alessandra; Orsi, Emanuela; Cattaneo, Daniele; Resi, Veronica; Bucelli, Cristina; Orofino, Nicola; Sciumè, Mariarita; Elena, Chiara; Grancini, Valeria; Consonni, Dario; Orlandi, Ester Maria; Cortelezzi, Agostino | |
| Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms | 1-gen-2015 | Pecci, Alessandro; Necchi, Vittorio; Barozzi, Serena; Vitali, Agostina; Boveri, Emanuela; Elena, Chiara; Bernasconi, Paolo; Noris, Patrizia; Solcia, Enrico | |
| SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts | 1-gen-2015 | Malcovati, Luca; Karimi, M; Papaemmanuil, E; Ambaglio, I; Jädersten, M; Jansson, M; Elena, Chiara; Gallì, A; Walldin, G; DELLA PORTA, MATTEO GIOVANNI; Raaschou Jensen, K; Travaglino, E; Kallenbach, K; Pietra, D; Ljungström, V; Conte, S; Boveri, E; Invernizzi, Rosangela; Rosenquist, R; Campbell, Pj; Cazzola, Mario; Hellström Lindberg, E. | |
| Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia | 1-gen-2016 | Elena, Chiara; Galli', Anna; Such, E; Meggendorfer, M; Germing, U; Rizzo, Ettore; Cervera, J; Molteni, Elisabetta; Fasan, A; Schuler, E; Ambaglio, Ilaria; Lopez Pavia, M; Zibellini, S; Kuendgen, A; Travaglino, E; Sancho Tello, R; Catricala', Silvia; Vicente, Ai; Haferlach, T; Haferlach, C; Sanz, Gf; Malcovati, Luca; Cazzola, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile